Idorsia
Antonio Olivieri has extensive work experience in the pharmaceutical industry. antonio is currently serving as the Senior Vice President and Head of Global Medical Affairs at Idorsia Pharmaceuticals Ltd since November 2020. Prior to this, they held various leadership positions at Alexion Pharmaceuticals, Inc., including Vice President of Medical Affairs International & Japan from December 2018 to November 2020, Vice President of Head of International and Japan Medical Affairs from December 2018 to November 2020, and Vice President of Medical Affairs EMEA from November 2015 to November 2020. Before joining Alexion Pharmaceuticals, Antonio worked at GSK Vaccines from 2008 to 2015, where they held roles such as Director of Global Medical Affairs Leader from February 2013 to October 2015, Vaccine Development Leader of Travellers Vaccines from May 2010 to January 2013, and Head of Project Management Flu Vaccines from May 2008 to May 2010.
Antonio Olivieri pursued a Doctor of Medicine (M.D.) degree in the Pediatrics Residency Program at the University of Verona - Italy. Additionally, they attended the University of Verona, Italy, although the specific degree and field of study are not mentioned.
Idorsia
4 followers
Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.